Cubist Systematic Strategies, LLC Ionis Pharmaceuticals Inc Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$36.45 - $47.7 $8.84 Million - $11.6 Million	-242,480 Reduced 87.29%	35,311 $1.68 Million
Q1 2024 May 15, 2024	BUY	$42.03 - $53.55 $3.29 Million - $4.19 Million	78,314 Added 39.26%	277,791 $12 Million
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $8.66 Million - $10.3 Million	199,477 New	199,477 $10.1 Million
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $2.95 Million - $3.68 Million	84,961 New	84,961 $3.49 Million
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $2.14 Million - $2.68 Million	57,662 Added 81.9%	128,070 $4.84 Million
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $2.89 Million - $3.84 Million	-78,980 Reduced 52.87%	70,408 $3.11 Million
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $1.71 Million - $2.32 Million	53,858 Added 56.38%	149,388 $5.53 Million
Q1 2022 May 16, 2022	SELL	$29.88 - $37.04 $6.03 Million - $7.47 Million	-201,652 Reduced 67.85%	95,530 $3.54 Million
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $5.39 Million - $7.39 Million	210,428 Added 242.56%	297,182 $9.04 Million
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $3.07 Million - $3.71 Million	-91,388 Reduced 51.3%	86,754 $2.91 Million
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $6.15 Million - $8.42 Million	178,142 New	178,142 $7.11 Million
Q1 2021 May 17, 2021	SELL	$42.51 - $63.78 $3.35 Million - $5.03 Million	-78,852 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $755,151 - $1 Million	16,670 Added 26.81%	78,852 $4.46 Million
Q3 2020 Nov 16, 2020	BUY	$47.45 - $62.95 $2.75 Million - $3.64 Million	57,882 Added 1346.09%	62,182 $2.95 Million
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $1.57 Million - $2.05 Million	-33,607 Reduced 88.66%	4,300 $254,000
Q1 2020 May 15, 2020	BUY	$41.6 - $63.4 $149,468 - $227,796	3,593 Added 10.47%	37,907 $1.79 Million
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $1.53 Million - $1.86 Million	28,502 Added 490.4%	34,314 $2.07 Million
Q3 2019 Nov 14, 2019	SELL	$59.06 - $72.15 $2.35 Million - $2.88 Million	-39,872 Reduced 87.28%	5,812 $348,000
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $789,722 - $1.1 Million	-12,719 Reduced 21.78%	45,684 $2.94 Million
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $3.09 Million - $4.74 Million	58,403 New	58,403 $4.74 Million
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $40,073 - $55,014	-924 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $39,621 - $49,618	924 New	924 $48,000
Q2 2018 Aug 14, 2018	SELL	$40.53 - $50.7 $811,207 - $1.01 Million	-20,015 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$44.08 - $55.05 $264,568 - $330,410	-6,002 Reduced 23.07%	20,015 $882,000
Q4 2017 Feb 14, 2018	BUY	$50.3 - $64.39 $977,178 - $1.25 Million	19,427 Added 294.8%	26,017 $1.31 Million
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $300,240 - $392,566	6,590	6,590 $334,000

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

Vanguard Group Inc Valley Forge, PA

15.1M
Shares

$473 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

14.2M
Shares

$445 Million
0.34% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$324 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

8.74M
Shares

$275 Million
0.06% of portfolio
Bellevue Group Ag Kuesnacht, V8

7.87M
Shares

$247 Million
5.32% of portfolio

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.46B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account